Stockreport

Abivax Announces ABTECT Phase 3 Trial Achieves Key Enrollment Milestone

Abivax SA  (ABVX) 
PDF Abivax Announces ABTECT Phase 3 Trial Achieves Key Enrollment Milestone Phase 3 ABTECT Trial evaluating obefazimod in moderately to severely active ulcerative col [Read more]